2018, Number 2
<< Back Next >>
Rev Hematol Mex 2018; 19 (2)
Disorders of iron metabolism: Too little, too much, too late
Kahn MJ
Language: English
References: 11
Page: 73-76
PDF size: 273.85 Kb.
ABSTRACT
Elemental iron is essential for life and the biochemistry and physiology of iron balance
and metabolism are now understood at the molecular level. Although iron deficiency
remains a worldwide problem due to nutritional inadequacy, malabsorption, and blood
loss, iron is often easily replaced. On the opposite end of the spectrum, mutations in
genes responsible for normal iron hemostasis can result in hereditary hemochromatosis,
a disease of iron overload. In this paper, the molecular biology of iron will be discussed
in the context of human disease.
REFERENCES
Sotelo A, González-Osnaya L, Sánchez-Chinchillas A, Trejo A. Role of oxalate, phytate, tannins and cooking on iron bioavailability from foods commonly consumed in Mexico. Int J Food Sci Nutr 2010;61:29-39.
Reichert CO, da Cunha J, Levy D, Maselli LMF, Bydlowski SP, Spada C. Hepcidin: Homeostasis and diseases related to iron metabolism. Acta Haematol 2017;137:220-236.
Wang J, Pantopoulos K. Regulation of cellular iron metabolism. Biochem J 2011;434:365-81.
Moretti D, Goede JS, Zeder, et al. Oral iron supplements increase hepcidin and decrease iron absorption form daily or twice-daily dose in iron depleted young women. Blood 2015;126:1981-9.
Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice daily split dosing in iron-depleted women: two open-lable, randomised controlled trials. Lancet Haematol 2017;11:e524-e533.
Christenson WN, Grace WJ, Henley ED, Wolff HG. Absorption of iron from the gastrointestinal tract; a comparative study of the oral iron tolerance test in human beings using stable and radioactive iron. Am J Clin Nutr 1956;4:609-18.
Eliadoue E, Kini G, Huang J, Champion A, Inns SJ. Intravenous iron replacement improves quality of life in hypoferritinemic inflammatory bowel disease patients with and without anemia. Dig Dis 2017;35:444-448.
Macdougall IC. Strategies for iron supplementation: oral versus intravenous. Kidney Int Suppl 1999;69:S61-6.
Poggiali E, Andreozzi F, Nava I, Consonni D, Graziadei G, Cappellini MD. The role of TMPRSS6 polymorphisms in iron deficiency anemia partially responsive to oral iron treatment. Am J Hematol 2015;90:306-9.
Gerhard GS, Paynton BV, DiStefano JK. Identification of genes for hereditary hemochromatosis. Methods Mol BiolA 2018;1706:353-365.
Casu C, Nemeth R, Rivella S. Hepcidin agonists as therapeutic tools. Blood 2018;Mar 9 [epub ahead of print].